Fulcrum Therapeutics, Inc. (FULC)
NASDAQ: FULC · Real-Time Price · USD
2.760
-0.120 (-4.17%)
At close: Apr 1, 2025, 4:00 PM
2.807
+0.047 (1.71%)
After-hours: Apr 1, 2025, 6:14 PM EDT

Fulcrum Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2017
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2017
Market Capitalization
149254417379717319
Upgrade
Market Cap Growth
-39.25%-39.25%10.13%-47.15%124.42%-14.89%
Upgrade
Enterprise Value
-835172171477192
Upgrade
Last Close Price
2.764.706.757.2817.6911.71
Upgrade
PS Ratio
2.143.17148.7759.7537.4136.21
Upgrade
PB Ratio
0.611.041.771.913.393.36
Upgrade
P/TBV Ratio
1.041.041.771.913.393.36
Upgrade
EV/Sales Ratio
0.070.0761.2126.9924.8721.82
Upgrade
Debt / Equity Ratio
0.040.040.050.07-0
Upgrade
Asset Turnover
0.310.310.010.030.110.07
Upgrade
Quick Ratio
22.1322.1317.4412.2011.584.33
Upgrade
Current Ratio
22.6322.6317.7112.4111.774.47
Upgrade
Return on Equity (ROE)
-4.07%-4.07%-44.84%-53.53%-52.72%-77.68%
Upgrade
Return on Assets (ROA)
-4.78%-4.78%-28.56%-30.36%-27.79%-37.30%
Upgrade
Return on Capital (ROIC)
-4.98%-4.98%-30.18%-33.07%-33.03%-49.08%
Upgrade
Earnings Yield
-6.53%-3.84%-23.33%-28.99%-11.28%-22.17%
Upgrade
FCF Yield
-1.68%-0.98%-21.92%-26.13%-11.19%-17.21%
Upgrade
Buyback Yield / Dilution
-1.10%-1.10%-36.27%-27.23%-39.47%-129.53%
Upgrade
Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q